otsuka cns:Otsuka's open innovation
Otsuka's open innovation
Westrivetoimprovethehealthofpatientsaroundtheworldwithunmetmedicalneedsinthefieldsofthecentralnervoussystem(CNS)andoncology,aswellas ...。其他文章還包含有:「CentralNervousSystem」、「CNSareaProductstory」、「OurBusiness」、「OurLeadership」、「Pharmaceuticals|OurBusinesses」、「Pipeline」、「Products」、「Research」、「WhoWeAre」
查看更多 離開網站Central Nervous System
https://www.otsuka.co.jp
Otsuka Pharmaceutical is dedicated to delivering highly innovative drugs to treat diseases of the central nervous system (CNS).
CNS area Product story
https://www.otsuka.co.jp
The difficulty in pinpointing the causes of diseases of the central nervous system presents a challenge to new drug development.
Our Business
https://www.otsuka.co.jp
In the central nervous system (CNS) field, building on the success of our globally recognized antipsychotic drug ABILIFY, in 2013 we launched ABILIFY ...
Our Leadership
https://www.otsuka-us.com
Our diverse leadership shares the goal of developing breakthrough therapies and contributing to the future of medicine to help people live healthier lives.
Pharmaceuticals | Our Businesses
https://www.otsuka.com
Otsuka focuses on the fields of psychiatry, neurology and oncology as priority areas under the theme of addressing unmet medical needs.
Pipeline
https://www.otsuka.co.jp
Researchers at Otsuka Pharmaceutical carry out original research and development to both help find cures for diseases and to maintain people's health.
Products
https://www.otsuka-us.com
Our product specialties include neuroscience, digital innovation, nephrology, oncology, and medical devices. Image.
Research
https://www.otsuka-us.com
Otsuka's commitment to providing innovative solutions for mental health disorders started more than 30 years ago. ... Each central nervous system (CNS) disorder ...
Who We Are
https://www.otsuka-us.com
Otsuka is a global healthcare company with two US offices and a network of 183 companies operating in 28 countries around the globe.